Literature DB >> 18625164

Treating prehypertension: a review of the evidence.

Norman M Kaplan1.   

Abstract

Although the term "prehypertension" has been challenged by some, its use to define people with systolic blood pressure (BP) between 120 and 139 mm Hg and/or diastolic pressures between 80 and 89 mm Hg has gained general acceptance. The category includes as many people as the number who have hypertension, defined as blood pressure of 140/90 or above. Such people are clearly at an increased risk of cardiovascular damage compared with people with BPs below 120/80 mm Hg. The major unresolved issue is the appropriate management of such patients. Two trials have attempted to document the value of short-term drug therapy to prevent the progression of BP to overt hypertension, but no outcome studies are currently available.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18625164     DOI: 10.1007/s11906-008-0060-8

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  18 in total

1.  Exercise capacity and blood pressure associations with left ventricular mass in prehypertensive individuals.

Authors:  Peter Kokkinos; Andreas Pittaras; Puneet Narayan; Charles Faselis; Steven Singh; Athanasios Manolis
Journal:  Hypertension       Date:  2006-11-06       Impact factor: 10.190

2.  Effects of normal blood pressure, prehypertension, and hypertension on coronary microvascular function.

Authors:  Dogan Erdogan; Ibrahim Yildirim; Ozgur Ciftci; Ismail Ozer; Mustafa Caliskan; Hakan Gullu; Haldun Muderrisoglu
Journal:  Circulation       Date:  2007-02-06       Impact factor: 29.690

3.  Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis.

Authors:  Ilke Sipahi; E Murat Tuzcu; Paul Schoenhagen; Katherine E Wolski; Stephen J Nicholls; Craig Balog; Timothy D Crowe; Steven E Nissen
Journal:  J Am Coll Cardiol       Date:  2006-06-15       Impact factor: 24.094

4.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

5.  Feasibility of treating prehypertension with an angiotensin-receptor blocker.

Authors:  Stevo Julius; Shawna D Nesbitt; Brent M Egan; Michael A Weber; Eric L Michelson; Niko Kaciroti; Henry R Black; Richard H Grimm; Franz H Messerli; Suzanne Oparil; M Anthony Schork
Journal:  N Engl J Med       Date:  2006-03-14       Impact factor: 91.245

6.  Treatment of young subjects at high familial risk of future hypertension with an angiotensin-receptor blocker.

Authors:  Karin Skov; Hans Eiskjaer; Hans Erik Hansen; Jens Kristian Madsen; Stinne Kvist; Michael John Mulvany
Journal:  Hypertension       Date:  2007-05-07       Impact factor: 10.190

7.  Cardiovascular outcome in relation to progression to hypertension in the Copenhagen MONICA cohort.

Authors:  Tine Willum Hansen; Jan A Staessen; Haifeng Zhang; Christian Torp-Pedersen; Susanne Rasmussen; Lutgarde Thijs; Hans Ibsen; Jørgen Jeppesen
Journal:  Am J Hypertens       Date:  2007-05       Impact factor: 2.689

8.  Prehypertension increases the risk for renal arteriosclerosis in autopsies: the Hisayama Study.

Authors:  Toshiharu Ninomiya; Michiaki Kubo; Yasufumi Doi; Koji Yonemoto; Yumihiro Tanizaki; Kazuhiko Tsuruya; Katsuo Sueishi; Masazumi Tsuneyoshi; Mitsuo Iida; Yutaka Kiyohara
Journal:  J Am Soc Nephrol       Date:  2007-06-20       Impact factor: 10.121

9.  Association between serum uric acid and prehypertension among US adults.

Authors:  Shirmila Syamala; Jialiang Li; Anoop Shankar
Journal:  J Hypertens       Date:  2007-08       Impact factor: 4.844

10.  Alteration of the course of hypertension in the spontaneously hypertensive rat.

Authors:  E D Freis; D Ragan; H Pillsbury; M Mathews
Journal:  Circ Res       Date:  1972-07       Impact factor: 17.367

View more
  1 in total

1.  Flavanols, the Kuna, cocoa consumption, and nitric oxide.

Authors:  Norman K Hollenberg; Naomi D L Fisher; Marjorie L McCullough
Journal:  J Am Soc Hypertens       Date:  2009-02-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.